1 Day
Source:
المصري اليوم
_1777352142843_145525226.png&w=48&q=75){kind=small}
TOFA Targets Obesity by Burn Fat
American researchers have revealed an experimental compound known as "TOFA" that has shown promising results in reducing fat and improving indicators of diabetes and fatty liver disease, while preserving muscle mass. This is achieved by increasing the body's energy expenditure rather than suppressing appetite. Experiments on mice demonstrated that the compound decreased fat and glucose levels without negatively affecting muscles, in addition to improving insulin sensitivity and triglyceride levels. "TOFA" is considered a potential supplement to obesity medications, especially when combined with appetite-suppressing drugs. However, it is still in the testing phase and has not yet proven safe and effective in humans. More studies are needed before it can be approved as a treatment for obesity or diabetes.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)